Tips for Fighting Payment Processing Fees in Medical Payments
Insurance companies and government agencies are increasingly using plastic and virtual credit cards to pay doctors. But practices can request other payment methods that carry lower fees.
Medical Card Pays for Endorsements
GE Capital's CareCredit card pays dozens of professional societies to help market its high-rate health care credit card, raising questions that could cloud the doctor-patient relationship.
Should You Charge a Medical Bill on a Rewards Credit Card?
Should you put the bill on your favorite rewards credit card? Here are some things to consider before pulling out your card.
Credit Card Debt Causes People to Forgo Medical Care
A study by a pair of University of Michigan sociologists finds people who are ill and don't seek treatment because of the cost are more likely to have credit card debt than other forms of debt.
Buying Insurance Based on Your Genetics
Insurance is a bet, so knowing your genetic destiny changes the odds.
From Trainer to CEO: How Barry's Bootcamp Plans To Get Even Bigger
With a new CEO and financial backing from North Castle, boutique fitness brand, Barry’s Bootcamp is looking to grow in new territories.
Johnson & Johnson Inks $4B Sale of Ortho Arm to Carlyle
Johnson & Johnson signed off on a $4 billion bid from private-equity giant Carlyle Group to acquire the blue-chip company’s blood-testing business.
J&J Unloads Diagnostics Unit to Carlyle for $4.15B
Johnson & Johnson received a $4.15 billion offer to sell its slow-growing ortho-clinical diagnostics business to private-equity firm Carlyle Group.
Report: Carlyle on the Verge of Acquiring J&J's Blood-Testing Unit for $4B
Johnson & Johnson is reportedly nearing a deal to sell its ortho clinical diagnostics division to Carlyle for about $4 billion.
KKR Places $1.67B Bet on Japan in Deal for Panasonic Healthcare
Marking the private-equity giant’s ever investment in Japan, KKR unveiled a deal to acquire Panasonic Healthcare from Panasonic for $1.7 billion.
Are We Any Closer to Finding a Drug to Battle Alzheimer’s?
While two potential drugs to treatment Alzheimer's show progress, it is not fast enough for the 5.3 million patients suffering from the disease.
Merck board approves repurchase of $10 billion more in stock
Merck & Co. says its board approved the repurchase of up to $10 billion more of its stock.
Pfizer to repurchase $5 billion in stock as part of $11 billion authorization
Pfizer will buy back $5 billion of its stock under an agreement with Goldman Sachs.
Gilead posts solid 4th-quarter results and announces stock buyback and dividend; shares slip
Gilead Sciences Inc. said Tuesday that sales of its newest hepatitis C drug, Harvoni, totaled $2.11 billion in the fourth quarter.
Drugmaker Pfizer says it will buy back as much as $11 billion more in stock
Drugmaker Pfizer says it approved the repurchase of $11 billion in company stock.
UnitedHealth Raises Dividend 34%
The world's largest health insurer raised its dividend by 34% on Wednesday and renewed its buyback program.
Deal Frenzy: 2014 Sees Record M&A Volume
A blockbuster year for deal making: 2014 is on track to see the greatest volume of M&A transactions on record thanks to 7,823 year-to-date proposals.
The Top 10 M&A Deals in History
Verizon Communications’ $130 billion deal to take full control of its wireless joint venture with Vodafone debuts at No. 2 among the largest-ever mergers and acquisition transactions.
Berkshire Profit Doubles to Record on Kraft Heinz
Warren Buffett's Berkshire Hathaway Inc said quarterly profit doubled to a record, reflecting a large gain on its stake in Kraft Heinz Co , while operating profit declined.
New App Lets You Get Instant Healthcare Through Your Smartphone
The "Doctor on Demand" app, which launched in 15 states this week, let patients skip the traditional visit to the doctor's office for a video chat instead.















